{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:00:14Z","timestamp":1783612814358,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012754","name":"Horizon Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract\u00a0<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Chronic granulomatous disease (CGD) is an uncommon, inborn error of immunity. We updated our large, single-center US experience with CGD and describe some newly recognized features.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively reviewed 26 patients seen from November 2013 to December 2019. Serious infections required intravenous antibiotics or hospitalization.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 21 males and 5 females. The most frequent infectious agents at presentation were aspergillus (4), serratia (4), burkholderia (2), <jats:italic>Staphylococcus aureus<\/jats:italic> (2), and klebsiella (2). The most common serious infections at presentation were pneumonia (6), lymphadenitis (6), and skin abscess (3). Our serious infection rate was 0.2 per patient-year from December 2013 through November 2019, down from 0.62 per patient-year from the previous study period (March 1985\u2013November 2013). In the last 6\u00a0years, four patients were evaluated for human stem cell transplantation, two were successfully transplanted, and we had no deaths. Several patients had unusual infections or autoimmune manifestations of disease, such as pneumocystis pneumonia, basidiomycete\/phellinus fungal pneumonia, and retinitis pigmentosa. We included one carrier female with unfavorable Lyonization in our cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We update of a large US single-center experience with CGD and describe some recently identified features of the illness.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10875-022-01294-6","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T11:22:39Z","timestamp":1655119359000},"page":"1411-1419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chronic Granulomatous Disease: an Updated Experience, with Emphasis on Newly Recognized Features"],"prefix":"10.1007","volume":"42","author":[{"given":"Zacharoula","family":"Oikonomopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanford","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Mets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-2388","authenticated-orcid":false,"given":"Ben","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"issue":"1","key":"1294_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1152\/ajplegacy.1932.103.1.235","volume":"103","author":"CW Baldridge","year":"1932","unstructured":"Baldridge CW, Gerard RW. The extra respiration of phagocytosis. Am J Physiol. 1932;103(1):235\u20136.","journal-title":"Am J Physiol"},{"issue":"4","key":"1294_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archpedi.1959.02070010389004","volume":"97","author":"RA Bridges","year":"1959","unstructured":"Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood. Am J Dis Child. 1959;97(4):387\u2013408.","journal-title":"Am J Dis Child"},{"key":"1294_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archpedi.1967.02090250068002","volume":"114","author":"RB Johnston","year":"1967","unstructured":"Johnston RB, McMurry JS. Chronic familial granulomatosis: report of five cases and review of the literature. Amer J Dis Child. 1967;114:370\u20138.","journal-title":"Amer J Dis Child"},{"issue":"5","key":"1294_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJM198302033080503","volume":"308","author":"AW Segal","year":"1983","unstructured":"Segal AW, Cross AR, Garcia RC, et al. Absence of cytochrome b-245 in chronic granulomatous disease \u2013 a multicenter European evaluation of its incidence and relevance. N Engl J Med. 1983;308(5):245\u201351.","journal-title":"N Engl J Med"},{"key":"1294_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1651-2227.1995.tb13575.x","volume":"84","author":"A Ahlin","year":"1995","unstructured":"Ahlin A, De Boer M, Roos D, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr. 1995;84:1386\u201394.","journal-title":"Acta Paediatr"},{"issue":"3","key":"1294_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine. 2000;79(3):155\u201369.","journal-title":"Medicine"},{"key":"1294_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2249.2008.03644.x","volume":"152","author":"LBKR Jones","year":"2008","unstructured":"Jones LBKR, McGrogan P, Flood TY, et al. Special article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152:211\u20138.","journal-title":"Clin Exp Immunol"},{"key":"1294_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clim.2008.06.012","volume":"129","author":"B Wolach","year":"2008","unstructured":"Wolach B, Gavrieli R, de Boer M, et al. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin Immunol. 2008;129:103\u201314.","journal-title":"Clin Immunol"},{"key":"1294_CR9","doi-asserted-by":"crossref","unstructured":"Van den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulomatous disease: the European experience. PLoS ONE 2009;4(4)L:e5234.","DOI":"10.1371\/journal.pone.0005234"},{"issue":"suppl 1","key":"1294_CR10","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1093\/jpids\/piy008","volume":"7","author":"NL Rider","year":"2018","unstructured":"Rider NL, Jameson MB, Creech CB. Chronic granulomatous disease. J Pediatric Infect Dis Soc. 2018;7(suppl 1):S2\u20135.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"1294_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1067\/mpd.2000.109112","volume":"137","author":"J Liese","year":"2000","unstructured":"Liese J, Klos S, Jendrossek V, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr. 2000;137:687\u201393. https:\/\/doi.org\/10.1067\/mpd.2000.109112.","journal-title":"J Pediatr"},{"key":"1294_CR12","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s00431-008-0680-7","volume":"167","author":"S Kobayashi","year":"2008","unstructured":"Kobayashi S, Murayama S, Takanashi S, et al. Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan. Eur J Pediatr. 2008;167:1389\u201394. https:\/\/doi.org\/10.1007\/s00431-008-0680-7.","journal-title":"Eur J Pediatr"},{"key":"1294_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","volume":"126","author":"B Martire","year":"2008","unstructured":"Martire B, Rondelli R, Soresina A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol. 2008;126:155\u201364. https:\/\/doi.org\/10.1016\/j.clim.2007.09.008.","journal-title":"Clin Immunol"},{"key":"1294_CR14","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","volume":"363","author":"DB Kuhns","year":"2010","unstructured":"Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med. 2010;363:2600\u201310.","journal-title":"N Engl J Med"},{"key":"1294_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1542\/peds.35.3.405","volume":"35","author":"MJ Carson","year":"1965","unstructured":"Carson MJ, Chadwick DL, Brubaker CL, Cleland RS, Landing BH. Thirteen boys with progressive septic granulomatosis. Pediatrics. 1965;35:405\u201312.","journal-title":"Pediatrics"},{"key":"1294_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00006982-200306000-00012","volume":"23","author":"SJ Kim","year":"2003","unstructured":"Kim SJ, Kim JG, Yu YS. Chorioretinal lesions in patients with chronic granulomatous disease. Retina. 2003;23:360\u20135.","journal-title":"Retina"},{"key":"1294_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1157\/13106774","volume":"35","author":"P Soler-Palacin","year":"2007","unstructured":"Soler-Palacin P, Margareto C, Llobet P, et al. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol. 2007;35:83\u20139.","journal-title":"Allergol Immunopathol"},{"key":"1294_CR18","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa021931","volume":"348","author":"JI Gallin","year":"2003","unstructured":"Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348:2416\u201322.","journal-title":"N Engl J Med"},{"key":"1294_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0022-3476(83)80798-7","volume":"103","author":"RS Weening","year":"1983","unstructured":"Weening RS, Kabel P, Pijman P, Roos D. Continuous therapy with sulfamethoxazole-trimethorpim in patients with chronic granulomatous disease. J Pediatr. 1983;103:127\u201330.","journal-title":"J Pediatr"},{"key":"1294_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/infdis\/162.3.723","volume":"162","author":"DM Margolis","year":"1990","unstructured":"Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis. 1990;162:723\u20136.","journal-title":"J Infect Dis"},{"key":"1294_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJM199102213240801","volume":"324","author":"International Chronic Granulomatous Disease Cooperative Study Group","year":"1991","unstructured":"International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991;324:509\u201316.","journal-title":"N Engl J Med"},{"issue":"10","key":"1294_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1182\/blood.2020005590","volume":"136","author":"R Chiesa","year":"2020","unstructured":"Chiesa R, Wang J, Blok H-J, et al. Hematopoietic stem cell transplantation in chronic granulomatous disease: a study of 712 children and adults. Blood. 2020;136(10):1201\u201311.","journal-title":"Blood"},{"key":"1294_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13402","author":"C Dedieu","year":"2020","unstructured":"Dedieu C, Albert MH, Mahlaoui N, et al. Outcome of chronic granulomatous disease \u2013 conventional treatment vs stem cell transplantation. Pediatr Allergy Immunol. 2020. https:\/\/doi.org\/10.1111\/pai.13402.","journal-title":"Pediatr Allergy Immunol"},{"issue":"Suppl 1","key":"1294_CR24","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1093\/jpids\/piy011","volume":"7","author":"MD Keller","year":"2018","unstructured":"Keller MD, Notarangelo LD, Malech HL. Future of care for patients with chronic granulomatous disease: gene therapy and targeted molecular medicine. J Pediatr Infect Dis Soc. 2018;7(Suppl 1):S40\u20134.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"10","key":"1294_CR25","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/INF.0000000000000840","volume":"34","author":"P Bortoletto","year":"2015","unstructured":"Bortoletto P, Lyman K, Camacho A, Fricchione M, Khanolkar A, Katz BZ. Chronic granulomatous disease: a large, single-center US Experience. Pediatr Infect Dis J. 2015;34(10):1110\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"1294_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1128\/cdli.2.2.227-232.1995","volume":"2","author":"MR O\u2019Gorman","year":"1995","unstructured":"O\u2019Gorman MR, Corrochano V. Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease. Clin Diagn Lab Immunol. 1995;2:227\u201332.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1294_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000237660","volume":"114","author":"AD Crockard","year":"1997","unstructured":"Crockard AD, Thompson JM, Boyd NAM, Haughton DJ, McCluskey DR, Turner CP. Diagnosis and carrier detection of chronic granulomatous disease in five families by flow cytometry. Int Arch All Immunol. 1997;114:144\u201352.","journal-title":"Int Arch All Immunol"},{"key":"1294_CR28","doi-asserted-by":"crossref","unstructured":"Haidar G, Zerbe CS, Cheng M, Zelazny AM, Holland SM, Sheridan KR. Phellinus species: an emerging cause of refractory fungal infections in patients with X-linked chronic granulomatous disease, Mycoses 2017;60:155-60","DOI":"10.1111\/myc.12573"},{"issue":"1","key":"1294_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1542\/peds.2014-3856","volume":"136","author":"K Padilla","year":"2015","unstructured":"Padilla K, Logan L, Codispoti C, Jones C, van Opstal E. Persistent pneumonia in an infant. Pediatrics. 2015;136(1):154\u201360.","journal-title":"Pediatrics"},{"key":"1294_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ymgme.2009.08.007","volume":"99","author":"S Balasubramaniam","year":"2010","unstructured":"Balasubramaniam S, Ruddock CM, Bennetts B, Peters G, Wilcken B, Ellaway C. Contiguous gene deletion syndrome in a female with ornithine transcarbamylase deficiency. Mol Genet Metab. 2010;99:34\u201341.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1294_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jaci.2017.04.035","volume":"141","author":"BE Marciano","year":"2018","unstructured":"Marciano BE, Zerbe CS, Falcone EL, et al. X-linked carriers of chronic granulomatous disease. J All Clin Immunol. 2018;141(1):365\u201371.","journal-title":"J All Clin Immunol"},{"issue":"7","key":"1294_CR32","doi-asserted-by":"publisher","first-page":"19017","DOI":"10.1053\/j.gastro.2008.02.081","volume":"134","author":"JJ Feld","year":"2008","unstructured":"Feld JJ, Hussain N, Wright E, et al. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology. 2008;134(7):19017\u201326.","journal-title":"Gastroenterology"},{"key":"1294_CR33","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","volume":"383","author":"T Gungor","year":"2014","unstructured":"Gungor T, Teira P, Slatter G, et al. Reduced-intensity conditioning and HLA-matched haematopoetic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014;383:436\u201348.","journal-title":"Lancet"},{"issue":"6","key":"1294_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/QCO.0b013e328358b0a4","volume":"25","author":"EL Falcone","year":"2012","unstructured":"Falcone EL, Holland SM. Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management. Curr Opinion Infect Dis. 2012;25(6):658\u201369.","journal-title":"Curr Opinion Infect Dis"},{"key":"1294_CR35","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0022-3476(99)70299-4","volume":"134","author":"D Goldblatt","year":"1999","unstructured":"Goldblatt D, Butcher J, Thrasher AJ, Russei-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr. 1999;134:780\u20133.","journal-title":"J Pediatr"},{"key":"1294_CR36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jaapos.2009.05.011","volume":"13","author":"S Al-Muhsen","year":"2009","unstructured":"Al-Muhsen S, Al Hemidan A, Al-Shehri A, et al. Ocular manifestations in chronic granulomatous disease in Saudi Arabia. J Amer Assoc Pediatr Ophthalmol Strabismus. 2009;13:396\u20139.","journal-title":"J Amer Assoc Pediatr Ophthalmol Strabismus"},{"issue":"9","key":"1294_CR37","first-page":"2712","volume":"40","author":"S Dror","year":"2000","unstructured":"Dror S, Bruns G, McGee T, Sandberg M, Searson E, Dryja T. X-linked retinitis pigmentosa: mutation spectrum of the RPGR and RP2 genes and correlation with visual function. Invest Ophthalmol Vis Sci. 2000;40(9):2712\u201321.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1294_CR38","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/bjo.83.10.1144","volume":"83","author":"C Flaxel","year":"1999","unstructured":"Flaxel C, Jay M, Thiselton D, et al. Difference between RP2 and RP3 phenotypes in X-linked retinitis pigmentosa. British J Ophthalmol. 1999;83:1144\u20138.","journal-title":"British J Ophthalmol"},{"key":"1294_CR39","doi-asserted-by":"crossref","unstructured":"Coman D, Yaplito-Lee J, La P et al. Three Mendelian disorders (chronic granulomatous disease, retinitis pigmentosa, ornithine transcarbamalase deficiency) in a young woman with an X chromosome deletion, del(X)(p11.4p21.1) Mol Gen Metab 2010;99:329;l","DOI":"10.1016\/j.ymgme.2009.11.006"},{"key":"1294_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1365-2133.1981.tb08163.x","volume":"104","author":"F Brandrup","year":"1981","unstructured":"Brandrup F, Koch C, Petri M, Schiodt M, Johansen KS. Discoid lupus erythematosus-like lesions and stomatitis in female carriers of X-linked chronic granulomatous disease. Brit J Dermatol. 1981;104:495\u2013505.","journal-title":"Brit J Dermatol"}],"updated-by":[{"DOI":"10.1007\/s10875-022-01370-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000}}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01294-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01294-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01294-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T19:18:55Z","timestamp":1668799135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01294-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01294-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10875-022-01370-x","asserted-by":"object"}]},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10875-022-01370-x","URL":"https:\/\/doi.org\/10.1007\/s10875-022-01370-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Stanley Mann Research Institute of the Ann & Robert H Lurie Children\u2019s Hospital of Chicago. Informed consent was not deemed necessary since this study consisted entirely of retrospective chart review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Katz is also a consultant for Horizon Pharma. No other author has any disclosure or any potential conflict of interest to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}